ChinaBio® Today Articles

Welcome to the ChinaBio® Today store. As a service to our readers, we offer access to individual articles for only $5.00 (USD) each.  Of course, a subscription is only $20/mo, so you may prefer to subscribe.  If so, click on Subscribe in the menu.

Browse


All Products

Viewing 1636 - 1650 of 5996 products
Abbisko Announces $123 Million Financing for Cancer Portfolio
$5.00
Available
Zai Labs Acquires China Rights to Novel Autoimmune Drug in $175 Million Deal
$5.00
Available
APT Medical Closes $191 Million Shanghai STAR Board IPO
$5.00
Available
Keya Medical Completes $46 Million Round for AI-based Scanning Software
$5.00
Available
Everest to Start China Phase III Trial of ADC For Urothelial Cancer
$5.00
Available
Terns Completes $87 Million Financing to Advance Three NASH Candidates
$5.00
Available
Paratek Closes $60 Million Loan Using Zai Lab Royalties for Pay Off
$5.00
Available
Shanghai Pharma to Build $1.8 Billion Novel Drug Facility in Zhangjiang Park
$5.00
Available
Ocumension Invests $15.7 Million In EyePoint of the US
$5.00
Available
ImmVira Completes C Round for Oncolytic Virus and Vector Candidates
$5.00
Available
InnoCare Approved to Launch BTK Inhibitor for Three Indications in China
$5.00
Available
Ascletis Doses First Person in US Trial of Novel NASH Treatment
$5.00
Available
Medbanks Closes $305 Million Financing for China Oncology Mega-Data
$5.00
Available
Chi-Med Approved to Market Surufatinib for Neuroendocrine Tumors
$5.00
Available
DXY.cn Raises $500 Million for On-line Physician Support and Healthcare Services
$5.00
Available